BDTX Earnings & Financial Statements
Black Diamond Therapeutics, Inc.
$1.70
+$0.00(+0.07%)
43
Overall
80
Value
10
Tech
39
Quality
Market Cap
$97.67M
Volume
206.33K
52W Range
$1.60 - $4.94
Target Price
$9.06
BDTX earnings and financial statements: Black Diamond Therapeutics, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
BDTX Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $70.00M | $3.05M | $1.14M | - | - |
| Operating income | $12.52M | -$78.78M | -$86.46M | -$92.83M | -$126.87M |
| EBITDA | $22.69M | -$69.33M | -$82.00M | -$92.32M | -$126.67M |
| Net income | $22.37M | -$69.68M | -$82.44M | -$91.17M | -$125.60M |
| EPS (diluted) | $0.39 | $-1.27 | $-1.88 | $-2.52 | $-3.47 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $143.01M | $122.64M | $158.57M | $156.25M | $247.68M |
| Total liabilities | $30.80M | $39.35M | $41.83M | $40.56M | $51.78M |
| Shareholders’ equity | $112.21M | $83.28M | $116.74M | $115.69M | $195.90M |
| Cash and equivalents | $20.99M | $36.44M | $56.22M | $34.31M | $65.80M |
| Long-term debt | $15.07M | $18.78M | $22.18M | $25.30M | $28.14M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $29.61M | -$62.30M | -$66.72M | -$85.08M | -$100.15M |
| Capital expenditure | $27.0K | $94.0K | -$33.0K | -$192.0K | -$2.71M |
| Free cash flow | $29.61M | -$62.30M | -$66.75M | -$85.27M | -$102.86M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BDTX | $1.70 | +0.1% | 206.33K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Black Diamond Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW